| 2515 |
1946: Altered mechanotransduction properties of pericytes |
1947: Pericyte dysfunction |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2517 |
1787: Downregulation of ACE2 |
1935: Ang (1-7) levels reduced |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2518 |
1935: Ang (1-7) levels reduced |
1936: Degradation of Ang-II reduced |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2519 |
1936: Degradation of Ang-II reduced |
1741: Induced, Angiotensin (Ang) II accumulation |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2520 |
1741: Induced, Angiotensin (Ang) II accumulation |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2521 |
1853: Hyperactivation of ACE/Ang-II/AT1R axis |
1535: Heart failure |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2522 |
1739: Binding to ACE2 |
1937: ADAM17 induction |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2523 |
1937: ADAM17 induction |
1938: ACE2 increased shedding |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2524 |
1938: ACE2 increased shedding |
1935: Ang (1-7) levels reduced |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 449 |
12: AchE Inhibition |
444: Increased, Atrioventricular block and bradycardia |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 428 |
351: Increased Mortality |
442: Decreased, Population trajectory |
Nov 29, 2016 |
Dec 20, 2019 |
None
|
| 432 |
444: Increased, Atrioventricular block and bradycardia |
351: Increased Mortality |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 447 |
428: Delay, Developmental GABA shift |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 434 |
39: Increased Cholinergic Signaling |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 446 |
427: Down Regulation, K-Cl co-transporter 2 (KCC2) |
428: Delay, Developmental GABA shift |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 445 |
381: BDNF, Reduced |
427: Down Regulation, K-Cl co-transporter 2 (KCC2) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 439 |
413: Reduction, Testosterone synthesis in Leydig cells |
446: Reduction of testosterone |
Nov 29, 2016 |
Dec 2, 2016 |
None
|
| 443 |
425: Thyroidal Iodide, Decreased |
281: T4 in serum, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 340 |
380: Activation, Pre-MIE: Metabolism of AFB1 |
373: Formation, Pro-mutagenic DNA Adducts |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 342 |
376: Increased, Induced Mutations in Critical Genes |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 343 |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 344 |
373: Formation, Pro-mutagenic DNA Adducts |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 350 |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 352 |
373: Formation, Pro-mutagenic DNA Adducts |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|